Nathan Weinstein

Nathan Weinstein

Director – Healthcare Analyst
Nathan began his career interning at NGN Capital, a life sciences focused venture capital firm. Nathan went on to work at Sidoti & Company and CL King & Associates. At those firms, Nathan was involved with institutional equities, actively facilitating the distribution of equity research to investors including pension, mutual, and hedge-funds. Nathan provided his clients with long/short idea flow, proprietary surveys, corporate access and conferences and led a successful business development effort that on boarded a significant number of new clients. Nathan graduated from Binghamton University with degrees in Economics and English.

Companies Covered (By Industry)

BioTechnology

STML Stemline Therapeutics Inc.

Animal Health

KIN Kindred Biosciences

Medical Devices

DYNT Dynatronics
EKSO Ekso Bionics

Diagnostics

OPGN OpGen

Pharmaceuticals

ACST Acasti Pharma Inc.